Literature DB >> 2550912

Receptors for sensory neuropeptides in human inflammatory diseases: implications for the effector role of sensory neurons.

P W Mantyh1, M D Catton, C G Boehmer, M L Welton, E P Passaro, J E Maggio, S R Vigna.   

Abstract

Glutamate and several neuropeptides are synthesized and released by subpopulations of primary afferent neurons. These sensory neurons play a role in regulating the inflammatory and immune responses in peripheral tissues. Using quantitative receptor autoradiography we have explored what changes occur in the location and concentration of receptor binding sites for sensory neurotransmitters in the colon in two human inflammatory diseases, ulcerative colitis and Crohn's disease. The sensory neurotransmitter receptors examined included bombesin, calcitonin gene related peptide-alpha, cholecystokinin, galanin, glutamate, somatostatin, neurokinin A (substance K), substance P, and vasoactive intestinal polypeptide. Of the nine receptor binding sites examined only substance P binding sites associated with arterioles, venules and lymph nodules were dramatically up-regulated in the inflamed tissue. These data suggest that substance P is involved in regulating the inflammatory and immune responses in human inflammatory diseases and indicate a specificity of efferent action for each sensory neurotransmitter in peripheral tissues.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550912     DOI: 10.1016/0196-9781(89)90154-x

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  16 in total

Review 1.  Chronic pancreatitis: the perspective of pain generation by neuroimmune interaction.

Authors:  P Di Sebastiano; F F di Mola; D E Bockman; H Friess; M W Büchler
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

2.  Simultaneous immunohistochemical demonstration of vasoactive intestinal polypeptide and its receptor in human colon.

Authors:  W Kummer
Journal:  Histochem J       Date:  1990-05

3.  The effects of capsaicin upon electrogenic ion transport in rat descending colon.

Authors:  S Yarrow; J A Ferrar; H M Cox
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-11       Impact factor: 3.000

4.  Neuropeptides and nerve growth in inflammatory bowel diseases: a quantitative immunohistochemical study.

Authors:  C M Y Lee; R K Kumar; D Z Lubowski; E Burcher
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

5.  Neurotrophic and neuroimmune responses to early-life Pseudomonas aeruginosa infection in rat lungs.

Authors:  Silvia Cardenas; Mario Scuri; Lennie Samsell; Barbara Ducatman; Pablo Bejarano; Alexander Auais; Melissa Doud; Kalai Mathee; Giovanni Piedimonte
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-06-11       Impact factor: 5.464

6.  Expression of calcitonin gene-related peptide in rat pulp and periodontal tissues by indirect immunofluorescence method.

Authors:  Yingming Sun; Rui Tao; Mengjie Zhang; Xue Cao; Hong Wang; Lufeng Xue; Meng Wu
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2013-12

7.  Block of voltage-dependent sodium currents by the substance P receptor antagonist (+/-)-CP-96,345 in neurones cultured from rat cortex.

Authors:  M Caeser; G R Seabrook; J A Kemp
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

8.  CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin.

Authors:  C Pothoulakis; I Castagliuolo; J T LaMont; A Jaffer; J C O'Keane; R M Snider; S E Leeman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

9.  Gastrin releasing peptide receptor expression is decreased in patients with Crohn's disease but not in ulcerative colitis.

Authors:  W P ter Beek; E S M Muller; R A Van Hogezand; I Biemond; C B H W Lamers
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

10.  Bombesin improves survival from methotrexate-induced enterocolitis.

Authors:  K U Chu; S Higashide; B M Evers; S Rajaraman; J Ishizuka; C M Townsend; J C Thompson
Journal:  Ann Surg       Date:  1994-10       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.